Intervention Review

Anti-spasticity agents for multiple sclerosis

  1. David Shakespeare1,*,
  2. Mike Boggild2,
  3. Carolyn A Young2

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 20 OCT 2003

Assessed as up-to-date: 13 JUL 2003

DOI: 10.1002/14651858.CD001332

How to Cite

Shakespeare D, Boggild M, Young CA. Anti-spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD001332. DOI: 10.1002/14651858.CD001332.

Author Information

  1. 1

    Lancashire Teaching Hospitals Trust, Neuro-rehabilitation Unit, Preston, Lancashire, UK

  2. 2

    The Walton Centre for Neurology & Neurosurgery, Liverpool, UK

*David Shakespeare, Neuro-rehabilitation Unit, Lancashire Teaching Hospitals Trust, 32A Watling Street Rd, Preston, Lancashire, PR2 8DY, UK. david.shakespeare@lthtr.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 OCT 2003

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ahmed Toosy, Olga Ciccarelli, Alan Thompson, Multiple Sclerosis and Related Disorders, 2014,

    CrossRef

  2. 2
    Robert W. Motl, Ambulation and Multiple Sclerosis, Physical Medicine and Rehabilitation Clinics of North America, 2013, 24, 2, 325

    CrossRef

  3. 3
    Lawrence M. Samkoff, Andrew D. Goodman, Symptomatic Management in Multiple Sclerosis, Neurologic Clinics, 2011, 29, 2, 449

    CrossRef

  4. 4
    Christoph Maier, Ralf Baron, Jule Frettlöh, Rudolf van Schayck, Tim Hagenacker, Die Schmerztherapie, 2011,

    CrossRef

  5. 5
    Julie H.Y. Huang, Haroon Hameed, Steven P. Cohen, Essentials of Pain Medicine, 2011,

    CrossRef

  6. 6
    Alan J Thompson, Ahmed T Toosy, Olga Ciccarelli, Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions, The Lancet Neurology, 2010, 9, 12, 1182

    CrossRef

  7. 7
    Antonio Emanuele Elia, Graziella Filippini, Daniela Calandrella, Alberto Albanese, Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review, Movement Disorders, 2009, 24, 6
  8. 8
    Mandy Dunbar, Clinical Case Studies in Physiotherapy, 2009,

    CrossRef

  9. 9
    Christoph Maier, Ralf Baron, Jule Frettlöh, Rudolf H. van Schayck, Zaza Katsarava, Die Schmerztherapie, 2009,

    CrossRef

  10. 10
    Georges F. Vles, Anton J.A. de Louw, Lucianne A. Speth, Lodewijk W. van Rhijn, Yvonne J.M. Janssen-Potten, Jos G. Hendriksen, Johan S.H. Vles, Visual Analogue Scale to score the effects of Botulinum Toxin A treatment in children with cerebral palsy in daily clinical practice, European Journal of Paediatric Neurology, 2008, 12, 3, 231

    CrossRef

  11. 11
    Alec L. Meleger, Muscle Relaxants and Antispasticity Agents, Physical Medicine and Rehabilitation Clinics of North America, 2006, 17, 2, 401

    CrossRef

  12. 12
    Bhasker Amatya, Loredana La Mantia, Marina Demetrios, Fary Khan, Non pharmacological interventions for spasticity in multiple sclerosis, The Cochrane Library,
  13. 13
    Bhasker Amatya, Fary Khan, Loredana La Mantia, Marina Demetrios, Derick T Wade, Non pharmacological interventions for spasticity in multiple sclerosis, The Cochrane Library,
  14. 14
    Nigel L Ashworth, L E Satkunam, Dan Deforge, Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease, The Cochrane Library,
  15. 15
    Nigel L Ashworth, L E Satkunam, Dan Deforge, Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease, The Cochrane Library,